loading

Entrada Therapeutics Inc (TRDA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
90.51%
1.95
20.56 19.57 94.69 59.12
Operating Expenses
15.23%
48.80
42.35 41.23 41.27 38.01
Benefits Costs and Expenses
100.00%
-
37.91 - - -
Costs And Expenses
28.73%
48.80
37.91 41.23 41.27 38.01
Operating Income/Loss
115.00%
-46.85
-21.79 -21.66 53.42 21.11
Income/Loss From Continuing Operations Before Tax
111.24%
1.95
-17.35 19.57 55.03 23.50
Income Tax Expense/Benefit
0.178
- -1.86 2.758 1.831
Income/Loss From Continuing Operations After Tax
148.45%
-43.10
-17.35 -14.03 55.03 23.50
Net Income/Loss
148.45%
-43.10
-17.35 -14.03 55.03 23.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.65%
41.34
41.07 40.63 34.18 33.50
Diluted Average Shares
0.65%
41.34
41.07 40.63 35.51 34.79
Basic Earnings Per Share
147.62%
-1.04
-0.42 -0.35 1.61 0.70
Diluted Earnings Per Share
147.62%
-1.04
-0.42 -0.35 1.55 0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
자본화:     |  볼륨(24시간):